全关节置换术围手术期抗生素预防:单次剂量与多次剂量同样有效
该回顾性研究纳入2006至2017年20682例初次全关节置换术,比较单次预防性抗生素(4523例)与多次给药(16159例)的假体周围感染率;单次组总体感染率为0.60%(27/4523),多次组为0.88%(142/16159),单因素、多因素及倾向性评分匹配分析均显示两组无差异。作者结论认为初次全关节置换术后皮肤关闭后追加抗生素可能并非必需,无论患者术前假体周围感染风险高低。
要点
- 单次预防性抗生素组假体周围感染率为0.60%(27/4523),多次给药组为0.88%(142/16159)。
- 单因素分析调整比值比OR=0.674(p=0.064),多因素分析OR=0.755(p=0.205),倾向性评分匹配分析OR=0.746(p=0.277),均无统计学差异。
- 术前假体周围感染高风险患者中,多次给药未显示额外获益(p=0.136)。
核心结论
- 本研究支持初次全关节置换术皮肤关闭后追加抗生素可能并非必需,无论患者术前假体周围感染风险高低。
- 作者认为这项大型回顾性研究的发现凸显了开展随机前瞻性研究以制定指南的必要性。
研究设计与样本
- 回顾性研究,纳入2006至2017年施行的20682例初次全关节置换术。
- 单次预防性抗生素组4523例,多次抗生素组16159例。
- 对每例患者分配既往验证过的假体周围感染风险评分,识别1年内发生假体周围感染的患者。
- 采用多因素logistic回归分析控制潜在混杂因素,并进行倾向性评分匹配和回归调整分析。
- 证据等级:治疗性III级。
主要发现
- 单次抗生素组总体假体周围感染率为0.60%(27/4523),多次抗生素组为0.88%(142/16159)。
- 单次组与多次组假体周围感染率在单因素分析(调整OR=0.674,p=0.064)、多因素分析(OR=0.755,p=0.205)和倾向性评分匹配分析(OR=0.746,p=0.277)中均无差异。
- 术前假体周围感染高风险患者中,多次给药未显示额外获益(p=0.136)。
临床怎么用
- 作者结论认为初次全关节置换术皮肤关闭后追加抗生素可能并非必需,无论患者术前假体周围感染风险高低。
- 作者认为该回顾性研究的发现凸显了开展随机前瞻性研究以制定指南的必要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent surgical site infection prevention guidelines recommend that no additional prophylactic antibiotics be administered after the surgical incision is closed in clean-contaminated procedures. Although there is ample evidence to support this recommendation in non-arthroplasty surgery, there is concern about extending these guidelines to surgical procedures with an implant such as total joint arthroplasty (TJA). The aim of this study was to compare the efficacy of a single dose of prophylactic antibiotics with that of multiple doses of antibiotics for prevention of periprosthetic joint infection (PJI) in patients undergoing TJA. METHODS: A retrospective study of 20,682 primary TJAs carried out from 2006 to 2017 was performed. Patients who received a single dose of prophylactic antibiotics (n = 4,523) were compared with patients who received multiple doses of antibiotics (n = 16,159). A previously validated PJI risk score was assigned to each patient. Patients who developed PJI within 1 year were identified, and a multivariate logistic regression analysis was performed to control for potential confounders. Analyses using propensity score matching and regression adjustment were also performed. RESULTS: The overall PJI rate was 0.60% (27 of 4,523) for patients who received a single dose of antibiotics compared with 0.88% (142 of 16,159) for those who received multiple doses. There was no difference in the PJI rate between patients who received a single dose of antibiotics and those who received multiple doses in the univariate (adjusted odds ratio [OR] = 0.674, p = 0.064), multivariate (OR = 0.755, p = 0.205), or propensity score matched analysis (OR = 0.746, p = 0.277). Furthermore, multiple doses did not demonstrate any additional benefit for patients with a high preoperative risk of PJI (p = 0.136). CONCLUSIONS: This study supports the notion that the administration of additional antibiotics following skin closure may not be required for primary TJA, regardless of the patient's preoperative risk of PJI. The findings of this large retrospective study highlight the need for a randomized, prospective study on which to base guidelines. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Tan TL, Shohat N, Rondon AJ, et al. Perioperative Antibiotic Prophylaxis in Total Joint Arthroplasty: A Single Dose Is as Effective as Multiple Doses. J Bone Joint Surg Am. 2019. PMID: 30845037. doi:10.2106/JBJS.18.00336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。